EMBC Target Cut
Embecta's target price is cut due to weakening medtech sentiment, potentially impacting the stock's performance. This move reflects a broader trend in the medtech sector.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.